Duvyzat (also known as givinostat) works differently from many other treatments. It helps block certain enzymes in the body that can lead to inflammation and scarring in muscles. By doing this, it may help muscles stay healthier for longer and slow down the damage caused by DMD. The therapy has already been approved by the USA and EMA for those with Duchenne muscular dystrophy (DMD) aged 6 and older, based on results from a large Phase 3 clinical trial called EPIDYS.
The EPIDYS trial included 179 boys with DMD who were still able to walk. Over about a year and a half, participants received either Duvyzat or a placebo (non-medicinal ‘fake’ pill), along with standard treatments like steroids. The results showed that those taking Duvyzat experienced a slower decline in muscle strength and movement. In simple terms, they were able to maintain their physical abilities longer than those who did not receive the treatment.
One of the key updates is that Duvyzat appears to be effective even at lower doses. This is important because some patients need their dose reduced due to side effects. The new analysis showed that even when doses were lowered, boys still experienced benefits, including better performance on movement tests like climbing stairs and walking assessments. This gives doctors more flexibility to safely adjust treatment while still helping patients.
Researchers also looked closely at changes inside the muscles using MRI scans. In DMD, the muscle tissue is gradually lost and replaced by fat. The study found that boys taking Duvyzat had a slower loss of healthy muscle and less fat buildup in their leg muscles compared to those not on the treatment. This suggests the drug may help protect muscle over time, not just improve short-term function.
These findings are important for the DMD community because they provide more evidence that Duvyzat can slow disease progression and may be adaptable to individual patient needs. As researchers continue to study long-term outcomes and real-world use, this treatment offers hope for helping people with DMD maintain strength, mobility, and quality of life for longer.
Read the press release below to learn more.
Want to know more about Duchenne Research?
Scientists and medical experts have been tirelessly pursuing diverse approaches to defeat Duchenne muscular dystrophy. From tackling the root cause to alleviating symptoms, the field of research is vast and promising. Explore the various strategies being developed and tested, and gain insights into the future of muscular dystrophy treatment: